Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3357 studies found for:    Open Studies | "Carcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Intervention: Drug: MLN0128
2 Recruiting Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Laparoscopic liver resection;   Procedure: Open liver resection
3 Recruiting 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: 18F-FluoroethylCholine PET
4 Recruiting Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: The imaging biomarkers determined by MR-PET
5 Recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
6 Recruiting Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Sorafenib
7 Recruiting Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: liver Perfusion MRI
8 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
9 Recruiting A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Conditions: Advanced Adult Hepatocellular Carcinoma;   Advanced Fibrolamellar Carcinoma
Intervention: Drug: ENMD-2076
10 Recruiting Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: CF102;   Drug: Placebo
11 Not yet recruiting A Study of DC-CIK to Treat Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Dendritic and Cytokine-induced Killer Cells
12 Not yet recruiting Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Condition: Hepatocellular Carcinoma
Interventions: Genetic: GLYCAR T cells;   Drug: Cytoxan;   Drug: Fludarabine
13 Not yet recruiting Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety
Condition: Adenocystic Carcinoma
Intervention: Drug: Chidamide
14 Recruiting A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Device: CyberKnife
15 Recruiting Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx
Condition: Carcinoma, Squamous Cell
Intervention: Procedure: Neck Dissection
16 Recruiting RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma, Adult
Interventions: Drug: Chemotherapy drug;   Drug: Embolic agents;   Procedure: Simultaneously;   Procedure: Sequentially;   Device: Ablation
17 Recruiting Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: Itraconazole
18 Recruiting Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With 3 mg/kg BW Ipilimumab (Yervoy®) Versus Observation
Condition: Merkel Cell Carcinoma
Intervention: Drug: Ipilimumab
19 Not yet recruiting Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients
Condition: Neuroendocrine Carcinomas
Intervention: Drug: TLC 388
20 Not yet recruiting Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Donafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.